Positive Results for Phase II Topical CBD Osteoarthritis Study
Avecho has today published positive results from our Phase IIa Study examining the use of our proprietary topical CBD gel for the management of pain associated with arthritis of the hand.
Four week treatment with Avecho’s proprietary topical CBD formulation resulted in highly significant improvements (p<.001) in patient observed (i) reductions in pain, (ii) increases in grip strength, (iii) improvements in hand functionality, (iv) self-reported stiffness of the fingers, and (v) self-reported anxiety.
The Study was run in collaboration with the Lambert Initiative, a highly respected academic institute for the discovery, development, and optimisation of safe cannabinoid therapeutics. We are now planning larger placebo-controlled studies with the Lambert, to explore the full potential of this topical CBD treatment.
Results of the current Study will be presented by the Lambert Initiative at the 32nd Annual International Cannabinoid Research Society Symposium (ICRS) in Galway, Ireland, in June 2022 – a valuable opportunity to showcase our TPM™ formulations on the world stage.